NVNO Shares Outstanding History
Below is a table of the NVNO shares outstanding history going back to 8/10/2021:

Date NVNO Shares Outstanding
8/10/20218.51M
11/9/20219.47M

Also see: NVNO Market Cap History
NVNO YTD Return
NVNO Historical Shares Outstanding:
+44.98% CAGR
NVNO Historical Shares Outstanding: +44.98% CAGR

Mouse over chart for data details
8/10/2021 ...11/9/2021
enVVeno Medical is a medical device company developing tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease. Co.'s products which it is developing include: the VenoValve®, a porcine based device to be surgically implanted in the deep venous system of the leg to treat a debilitating condition called chronic venous deficiency; and the CoreoGraft®, a bovine based conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. We show 2 historical shares outstanding datapoints in our coverage of NVNO's shares outstanding history.

Understanding the changing numbers of NVNO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NVNO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NVNO by allowing them to research NVNO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree NVNO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
enVVeno Medical (NVNO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

NVO Shares Outstanding History
NVOS Shares Outstanding History
NVRO Shares Outstanding History
NVST Shares Outstanding History
NVTA Shares Outstanding History
NVTR Shares Outstanding History
NVUS Shares Outstanding History
NXTC Shares Outstanding History
NXTM Shares Outstanding History
NYMX Shares Outstanding History
More Healthcare companies »

 

NVNO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.